Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V78794 | 14-3-3σ/ERα stabilizer-1 | 14-3-3σ/ERα stabler-1 (Compound 181) is a covalent 14-3-3σ/ERα stabilizer. | |
![]() |
V40395 | Amcenestrant (SAR-439859) | 2114339-57-8 | Amcenestrant (SAR-439859; SAR439859) is a potent, orally available, and nonsteroidalestrogen receptor degrader (SERD)with potential anticancer activity. |
![]() |
V77195 | Bisphenol AF-d4 (BPAF-d4; 4,4'-(Perfluoropropane-2,2-diyl)diphenol-d4) | Bisphenol AF-d4 is an isotopically labeled analog of Bisphenol AF. | |
![]() |
V17164 | BTC (Estrogen receptor modulator 1) | 63676-22-2 | BTC, formerly known as RALOXIFENE CORE, is a selective andorally active estrogen receptor modulator (SERM) with apIC50of 0.46. |
![]() |
V79338 | ERα degrader 6 | ERα degrader 6 (Compound 31q) is an ERα degrader (KI: 75 nM). | |
![]() |
V78502 | ERα degrader 7 | ERα degrader 7 (Compound B1) is a potent ERα degrader with IC50 of 14.6 nM and a DC 50 of 9.7 nM. | |
![]() |
V79343 | ET receptor antagonist 1 | ET receptor antagonist 1 (compound 16h) is an ET receptor antagonist (IC50=0.18 nM) and may be utilized in pulmonary arterial hypertension (PAH) research. | |
![]() |
V79391 | ET receptor antagonist 2 | ET receptor antagonist 2 (compound 16j) is an ET receptor antagonist (IC50=0.22 nM) that may be utilized in pulmonary arterial hypertension (PAH) research. | |
![]() |
V78664 | ET receptor antagonist 3 | ET receptor antagonist 3 (compound 17d) is an ET receptor antagonist (IC50=0.26 nM) that may be utilized in pulmonary arterial hypertension (PAH) research. | |
![]() |
V79534 | Fulvestrant-d3 (ICI 182780-d3; ZD 9238-d3; ZM 182780-d3) | Fulvestrant-d3 is the deuterium labelled form of Fulvestrant. | |
![]() |
V31869 | H3B-5942 | 2052128-15-9 | H3B-5942 (H3B5942) is a selective, irreversible (covalent) and orally bioavailable estrogen receptor antagonist with antitumor activity (better than fulvestrant). |
![]() |
V76934 | hFSH-β-(33-53) (TFA) | hFSH-β-(33-53) TFA is a thiol-containing peptide corresponding to the second FSH receptor-binding domain and is an FSHR (follicle-stimulating hormone receptor) antagonist. | |
![]() |
V81275 | Raloxifene-d10 | Raloxifene-d10 is the deuterated form of Raloxifene. | |
![]() |
V73484 | Yp537 TFA (Anti-estrogen TFA) | Yp537 TFA is an estrogen receptor (ER) inhibitor that prevents dimerization of the human estrogen receptor. | |
![]() |
V1755 | Sinomenine (Cucoline) | 568-72-9 | Sinomenine(Coculine; Cucoline; Kukoline) is a naturally occuring alkaloid found in the root of the climbing plant Sinomenium acutum which is native to Japan and China. |
![]() |
V1752 | Ulipristal (CDB-2914) | 159811-51-5 | Ulipristal(CDB-2914;HRP2000, VA2914,RTI 3021-012, RU 44675, EllaOne, Ella, Esmya) is a potent and selective SPRM (selective progesterone receptor modulator) used for emergency contraception after an unprotected intercourse or contraceptive failure. |
![]() |
V1735 | Ethinyl Estradiol (Ethynylestradiol) | 57-63-6 | Ethinyl Estradiol (17α-Ethynylestradiol; Ginestrene; Ethinyl Estradiol; Ethynylestradiol; Microfollin Forte; Organon; Progynon C) is an orally bioactive and semi-synthetic estrogen used in various formulations of combined oral contraceptive pills. |
![]() |
V1756 | Tariquidar dimesylate | 625375-84-0 | Tariquidar dimesylate (formerly known as XR9576; D06008; XR-9576; D-06008), the dimesylate salt ofTariquidar, is a novel potent and selective noncompetitive inhibitor of P-glycoprotein (P-gp) with potential antitumor activity. |
![]() |
V10360 | Dydrogesterone | 152-62-5 | Dydrogesterone is a synthetic progestin. |
![]() |
V1733 | Dehydroepiandrosterone (DHEA) | 53-43-0 | Dehydroepiandrosterone (trans-Dehydroandrosterone; DHEA; Prasterone; Psicosterone; EL-10; GL-701; IP-1001;NSC-9896;PB-007; SH-K-04828; Androstenolone; Diandrone) is an endogenous steroidal hormone acting asan androgen receptor antagonist and an estrogen receptor agonist. |